Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Bladder cancer | R-HSA-9700206 | map05219 | flucytosine | 5198 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | flucytosine | 5198 | drug-path |
Thyroid cancer | R-HSA-9700206 | map05216 | flucytosine | 5198 | drug-path |
Gap junction | R-HSA-190861 | map04540 | flucytosine | 5198 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | flucytosine | 5198 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | clofazimine | 5880 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | clofazimine | 5880 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | clofazimine | 5880 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | clofazimine | 5880 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | alexidine | 2090 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | alexidine | 2090 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | alexidine | 2090 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | alexidine | 2090 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | alexidine | 2090 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | alexidine | 2090 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | alexidine | 2090 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | alexidine | 2090 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | alexidine | 2090 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | alexidine | 2090 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | alexidine | 2090 | drug-path |